U.S. flag An official website of the United States government
  1. Home
  2. Science & Research
  3. FDA Technology Transfer Program
  4. Licensing and Collaboration Opportunities
  5. Recently Issued U.S. Patents to FDA
  1. Licensing and Collaboration Opportunities

Recently Issued U.S. Patents to FDA

The following is a listing of U.S. Patents that were recently issued to FDA. These patents illustrate FDA’s commitment to protecting and advancing public health by helping to speed innovations that provide our nation with safe and effective medical products and that keep our food safe. These inventions are available for licensing. Please contact the Technology Transfer Program office. A complete listing of all FDA technologies that are available for licensing and collaboration is found here

By Year 

2016
2015
2014
2013


2016
United States patent 9,243,036 was issued on January 26, 2016, Antimicrobial activity of synthetic peptides.
FDA inventors: Chintamani Atreya; Shilpakala Sainath Rao, Krishna Mohan V. Ketha.

United States patent 9,266,928 was issued on February 23, 2016, for Deletion of the beta 20-21 loop in HIV GP120 exposes the CD4 binding site for improved antibody binding and antibody induction.
FDA inventor: Ira Berkower. 

2015

United States patent 8,968,719 was issued on March 3, 2015, for Live, oral vaccine for protection against Shigella dysenteriae serotype 1.
FDA inventors: Dennis J. Kopecko; De-Qi Xu.

United States patent 8,980,546 was issued on March 17, 2015, for Method for the detection of HIV-1-specific antibodies utilizing a VPU polypeptide.
FDA Inventors: Hana Golding; Surender Khurana.

United States patent 8,992,943 was issued on March 31, 2015, for Vaccine for protection against Shigella sonnei disease.
FDA inventors: Dennis J. Kopecko; De-Qi Xu; John O. Cisar.

United States patent 9,005,631 was issued on April 14, 2015, for Membrane proximal region of HIV GP41 anchored to the lipid layer of a virus-like particle vaccine.
FDA inventor: Ira Berkower.

United States patent 9,006,203 was issued on April 14, 2015, for Method of reducing inflammatory infiltration in subjects with inflammatory lung disease.
FDA inventors: Dennis M. Klinman; Hiroshi Yamada.

United States patent 9,103,788 was issued on August 11, 2015, for Detection of bacterial contamination in a sample.
FDA inventors: Jon G. Wilkes; Dan A. Buzatu; Randal K. Tucker.

United States patent 9,107,813 was issued on August 18, 2015, for Immunogenic compositions containing anthrax antigen, biodegradable polymer microparticles, and polynucleotide-containing immunological adjuvant.
FDA inventors: Derek T. O’Hagan; Manmohan Singh; Dennis M. Klinman.

United States patent 9,121,855 was issued on September 1, 2015, Methods for detection of HIV-1 antibodies utilizing a peptide containing a novel GP41 epitope.
FDA inventors: Hana Golding; Surender Khurana.

United States patent 9,163,068 was issued on October 20, 2015, for Influenza virus recombinant proteins.
FDA inventors: Surender Khurana; Hana Golding.

United States patent 9,163,244 was issued on October 20, 2015, for Suppressors of CpG oligonucleotides and methods of use.
FDA inventors: Dennis M. Klinman; Rainald Zeuner; Mayda Gursel; Ihsan Gursel; Daniela Verthelyi. 

United States patent 9,169,297 was issued on October 27, 2015, for Subgenomic replicons of the Flavivirus dengue.
FDA inventors: Xiaowu Pang; Andrew I. Dayton; Mingjie Zhang.

United States patent 8,557,250 was issued on November 3, 2015, for Methods for preparing complex multivalent immunogenic conjugates.
FDA inventor: Che-Hung Robert Lee.

United States patent 9,175,033 was issued on November 3, 2015, for Methods for preparing complex multivalent immunogenic conjugates.
FDA inventors: Che-Hung Robert Lee.

United States patent 9,181,306 was issued on November 10, 2015, for Insertion of foreign genes in Rubella virus and their stable expression in a live, attenuated viral vaccine.
FDA inventors: Ira Berkower; Angela Spadaccini.

United States patent 9,193,995 was issued on November 24, 2015, for Compositions for detecting human interferon-alpha subtypes and methods of use.
FDA inventors: Ronald Rabin; Viraj Pramod Mane.

United States patent 9,194,868 was issued on November 24, 2015, Flow cytometry-based systems and methods for detecting microbes.
FDA inventors: Dan A. Buzatu; Jon G. Wilkes; Ted A. Moskal; Bill Nevius; Jason T. Taylor; Randal K. Tucker; Melinda Miller; Shawn Ramsanoop.

United States patent 9,198,976 was issued on December 1, 2015, for Polysaccharide-protein conjugate vaccines.
FDA inventors: Che-Hung Robert Lee; Carl E. Frasch.

United States patent 9,205,276 was issued on December 8, 2015, for Light as a replacement for mitogenic factors in progenitor cells.
FDA inventors: Ilko K. Ilev; Ronald W. Waynant.  

2014

United States patent 8,628,782 was issued on January 14, 2014, for Deletion of the beta 20-21 loop in HIV GP120 exposes the CD4 binding site for improved antibody binding and antibody induction.
FDA inventor: Ira Berkower.

United States patent 8,652,801 was issued on February 18, 2014, for Hydrophilic IR transparent membrane, spectroscopic sample holder comprising same and method of using same.
FDA inventors: Magdi Mossoba; Sufian Al-Khaldi.

United States patent 8,680,065 was issued on March 25, 2014, for Oligonucleotides of human endogenous retrovirus 9 (ERV-9) long terminal repeat (LTR) and methods of use.
FDA inventors: Lai Xu; Amy S. Rosenberg; Abdel Elkahloun; Fabio Candotti.

United States patent 8,704,169 was issued in April 22, 2014, for Direct impact ionization (DII) mass spectrometry.
FDA inventors: Pierre Alusta; Cameron Dorey; William Ryan Parker; Jon G. Wilkes; Dan Buzatu.

United States patent 8,709,813 was issued on April 29, 2014, for DNA promoters and anthrax vaccines.
FDA inventors: Dennis J. Kopecko; Chandrakant P. Giri.

United States patent 8,722,324 was issued on May 13, 2014, Methods for detection of HIV-1-specific antibodies employing GP41 polypeptides.
FDA inventors: Hana Golding; Surender Khurana.

United States patent 8,741,869 was issued on June 3, 2014, for Oligonucleotides and its use to induce an immune response.
FDA inventors: Dennis M. Klinman; Ken J. Ishii; Daniela Verthelyi.

United States patent 8,753,649 was issued on June 17, 2014, for Polysaccharide-protein conjugate vaccines.
FDA inventors: Che-Hung Robert Lee; Carl E. Frasch.

United States patent 8,790,635 was issued on July 29, 2014, for Live, oral vaccine for protection against Shigella dysenteriae serotype 1.
FDA inventors: Dennis J. Kopecko; De-Qi Xu.

United States patent 8,778,847 was issued on July 15, 2014, for Immunogenic peptides of influenza virus.
FDA inventors: Hana Golding; Surender Khurana.

United States patent 8,880,354 was issued on November 4, 2014, for System for magnetic resonance spectroscopy of brain tissue for pattern-based diagnostics.
FDA inventors: Jon Wilkes; Dan A. Buzatu; Pierre Alusta; Bruce A. Pearce; Ryan M. Kretzer; Inessa Im; Richard Beger.

United States patent 8,877,213 was issued on November 4, 2014, for Live attenuated Leishmania vaccines.
FDA inventors: Hira L. Nakhasi; Angamuthu Selvapandiyan; Alain Debrabant; Robert C. Duncan.

United States patent 8,895,521 was issued on November 25, 2014, for Methods and compositions for treatment of uveitis.
FDA inventor: Dennis M. Klinman. 

2013

United States patent 8,383,359 was issued on February 26, 2013, for Use of lymphocytes to measure anthrax lethal toxin activity.
FDA inventors: David M. Frucht; Hui Fang.

United States patent 8,389,495 was issued on March 5, 2013, for Oligonucleotides and its use to induce an immune response.
FDA inventors: Dennis M. Klinman; Ken Ishii; Daniela Verthelyi.

United States patent 8,456,738 was issued on June 4, 2013, for Ultrahigh-resolution fiber-optic confocal microscope and method.
FDA inventors: Ilko K. Ilev; Ronald W. Waynant; Israel Gannot; Amir H. Gandjbakhche.

United States patent 8,465,749 was issued on June 18, 2013, for Polysaccharide-protein conjugate vaccines.
FDA inventors: Che-Hung Robert Lee; Carl E. Frasch.

United States patent 8,470,342 was issued on June 25, 2013, for Methods of altering an immune response induced by CpG oligodeoxynucleotides.
FDA inventors: Dennis M. Klinman; Mayda Gursel; Ihsan Gursel.

United States patent 8,481,055 was issued on July 9, 2013, for Method preventing infections from bioterrorism agents with immunostimulatory CpG oligonucleotides.
FDA inventors: Dennis M. Klinman; Bruce Ivins; Daniela Verthelyi.

United States patent 8,501,188 was issued on August 6, 2013, for Method of treating inflammatory lung disease with suppressors of CpG oligonucleotides.
FDA inventors: Dennis M. Klinman; Hiroshi Yamada.

United States patent 8,557,789 was issued on October 15, 2013, for Method of treating inflammatory anthropathies with suppressors of CpG oligonucleotides.
FDA inventors: Dennis M. Klinman; Rainald Zeuner; Daniela Verthelyi; Ihsan Gursel; Mayda Gursel.

United States patent 8,557,250 was issued on October 15, 2013, for Methods for preparing complex multivalent immunogenic conjugates.
FDA Inventor: Che-Hung Robert Lee.

United States patent 8,574,844 was issued on November 5, 2013, for Quantitative real-time assay for noroviruses and enteroviruses with built in quality control standard.
FDA inventors: William Burkhardt, III.; Michael C. L. Vickery; Jessica Nordstrom.

United States patent 8,580,944 was issued on November 12, 2013, for Suppressors of CpG oligonucleotides and methods of use.
FDA inventors: Dennis M. Klinman; Rainald Zeuner; Mayda Gursel; Ihsan Gursel; Daniela Verthelyi.

United States patent 8,603,468 was issued on December 10, 2013, for Neutralization of HCV.
FDA inventors: Pei  Zhang; Marian Major; Stephen Feinstone.